Over the past several years, it has become abundantly clear that molecular events not only can be defined in prostate cancer but also can affect the treatment of patients and can have important ...
BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...
Detailed price information for Cannabix Technologies Inc (BLO-CN) from The Globe and Mail including charting and trades.
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy Herein, we highlight the strengths ...
CD4 tests is strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, said the World Health Organization (WHO). The new recommendation is part of the ...
Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results